Related references
Note: Only part of the references are listed.Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis
Borbala Kiss et al.
EXPERIMENTAL DERMATOLOGY (2020)
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Tao Gong et al.
NATURE REVIEWS IMMUNOLOGY (2020)
DNA damage-induced PARP1 activation confers cardiomyocyte dysfunction through NAD+ depletion in experimental atrial fibrillation
Deli Zhang et al.
NATURE COMMUNICATIONS (2019)
PARP inhibition by olaparib alleviates chronic asthma-associated remodeling features via modulating inflammasome signaling in mice
Gurupreet S. Sethi et al.
IUBMB LIFE (2019)
ADP-ribosylation signalling and human disease
Luca Palazzo et al.
OPEN BIOLOGY (2019)
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers
Man Yee T. Keung et al.
JOURNAL OF CLINICAL MEDICINE (2019)
A decade of clinical development of PARP inhibitors in perspective
J. Mateo et al.
ANNALS OF ONCOLOGY (2019)
Inflammation-induced DNA damage, mutations and cancer
Jennifer Kay et al.
DNA REPAIR (2019)
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Panagiotis A. Konstantinopoulos et al.
JAMA ONCOLOGY (2019)
Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update
Priyancy G. Jain et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
Todd A. Hopkins et al.
MOLECULAR CANCER RESEARCH (2019)
PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3
Ling Ding et al.
CANCER IMMUNOLOGY RESEARCH (2019)
PARP-1 deregulation in multiple sclerosis
Maria Meira et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2019)
Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications
Lianhua Piao et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2018)
Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis
Aoife M. McGinley et al.
JOURNAL OF AUTOIMMUNITY (2018)
The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication
Hana Hanzlikova et al.
MOLECULAR CELL (2018)
PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression
Bastian Doersam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
NAD(+) analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains
Marie-France Langelier et al.
NATURE COMMUNICATIONS (2018)
PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation
George E. Ronson et al.
NATURE COMMUNICATIONS (2018)
Stressing the (Epi)Genome: Dealing with Reactive Oxygen Species in Cancer
Akshay V. Bhat et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
The comings and goings of PARP-1 in response to DNA damage
John M. Pascal
DNA REPAIR (2018)
Deletion of poly(ADP-ribose) polymerase-1 changes the composition of the microbiome in the gut
Andras Vida et al.
MOLECULAR MEDICINE REPORTS (2018)
PARP-1 regulates DNA repair factor availability
Matthew J. Schiewer et al.
EMBO MOLECULAR MEDICINE (2018)
Poly(ADP-ribose) drives pathologic α-synuclein neurodegeneration in Parkinson's disease
Tae-In Kam et al.
SCIENCE (2018)
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases
Nathan A. Berger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Microhomology-mediated end joining is activated in irradiated human cells due to phosphorylation-dependent formation of the XRCC1 repair complex
Arijit Dutta et al.
NUCLEIC ACIDS RESEARCH (2017)
Synthetic lethal genetic interactions between Rad54 and PARP-1 in mouse development and oncogenesis
Mirella Tanori et al.
ONCOTARGET (2017)
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Rebecca Gupte et al.
GENES & DEVELOPMENT (2017)
Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease
Karim Gariani et al.
JOURNAL OF HEPATOLOGY (2017)
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis
Partha Mukhopadhyay et al.
JOURNAL OF HEPATOLOGY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
Shiping Jiao et al.
CLINICAL CANCER RESEARCH (2017)
Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-ribose) Polymerase 1 (PARP1)-deficient Mice
Claire B. Larmonier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Charon Mediates Immune Deficiency-Driven PARP-1-Dependent Immune Responses in Drosophila
Yingbiao Ji et al.
JOURNAL OF IMMUNOLOGY (2016)
PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier
Slava Rom et al.
JOURNAL OF NEUROINFLAMMATION (2016)
PARP1 Links CHD2-Mediated Chromatin Expansion and H3.3 Deposition to DNA Repair by Non-homologous End-Joining
Martijn S. Luijsterburg et al.
MOLECULAR CELL (2016)
Inflammatory networks underlying colorectal cancer
Audrey Lasry et al.
NATURE IMMUNOLOGY (2016)
Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia
Fei Teng et al.
NEUROCHEMICAL RESEARCH (2016)
Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients
Kyoung Min Kim et al.
PLOS ONE (2016)
Cultured networks of excitatory projection neurons and inhibitory interneurons for studying human cortical neurotoxicity
Jin-Chong Xu et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer
Ying Liu et al.
ONCOLOGY LETTERS (2016)
The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1
Gang Li et al.
PLOS GENETICS (2016)
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy
Robert Fred Henry Walter et al.
JOURNAL OF CANCER (2016)
Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo
Colin Thomas et al.
EBIOMEDICINE (2016)
Analysis of the intricate relationship between chronic inflammation and cancer
Edna Zhi Pei Chai et al.
BIOCHEMICAL JOURNAL (2015)
The Streptococcus pyogenesNAD+ glycohydrolase modulates epithelial cell PARylation and HMGB1 release
Sukantha Chandrasekaran et al.
CELLULAR MICROBIOLOGY (2015)
Extracellular Poly(ADP-Ribose) Is a Pro-inflammatory Signal for Macrophages
Kristin A. Krukenberg et al.
CHEMISTRY & BIOLOGY (2015)
PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice
Mohamed A. Ghonim et al.
CLINICAL SCIENCE (2015)
Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP-1: New player in tumor progression
Paola Barboro et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Bella Kaufman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Downregulation of Poly(ADP-Ribose) Polymerase 1 by a Viral Processivity Factor Facilitates Lytic Replication of Gammaherpesvirus
Woo-Chang Cheong et al.
JOURNAL OF VIROLOGY (2015)
PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases
Sara Martire et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2015)
Mechanistic Dissection of PARP1 Trapping and the Impacton In Vivo Tolerability and Efficacy of PARP Inhibitors
Todd A. Hopkins et al.
MOLECULAR CANCER RESEARCH (2015)
RNA Regulation by Poly(ADP-Ribose) Polymerases
Florian J. Bock et al.
MOLECULAR CELL (2015)
Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance
Peter Bai
MOLECULAR CELL (2015)
Tumor suppressive effect of PARP1 and FOXO3A in gastric cancers and its clinical implications
See-Hyoung Park et al.
ONCOTARGET (2015)
Successes and challenges of PARP inhibitors in cancer therapy
Tiffany K. Ricks et al.
FRONTIERS IN ONCOLOGY (2015)
Genomic instability in chronic airway inflammatory diseases
Zhengqiang Bao et al.
BIOMEDICAL JOURNAL (2015)
PARP inhibitor, olaparib ameliorates acute lung and kidney injury upon intratracheal administration of LPS in mice
Kunal Kapoor et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Investigation of Poly (ADP-Ribose) Polymerase-1 Genetic Variants as a Possible Risk for Allergic Rhinitis
Ahmet Ozaydin et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)
Parp-1 genetic ablation in Ela-myc mice unveils novel roles for Parp-1 in pancreatic cancer
Neus Martinez-Bosch et al.
JOURNAL OF PATHOLOGY (2014)
PARP-1 Expression is Increased in Colon Adenoma and Carcinoma and Correlates with OGG1
Tomasz Dziaman et al.
PLOS ONE (2014)
Family-wide analysis of poly(ADP-ribose) polymerase activity
Sejal Vyas et al.
NATURE COMMUNICATIONS (2014)
Rationale for Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Combination Therapy with Camptothecins or Temozolomide Based on PARP Trapping versus Catalytic Inhibition
Junko Murai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue
M. Salemi et al.
EUROPEAN JOURNAL OF HISTOCHEMISTRY (2013)
Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival
Alex Gan et al.
HUMAN PATHOLOGY (2013)
Beyond DNA repair, the immunological role of PARP-1 and its siblings
Maria Manuela Rosado et al.
IMMUNOLOGY (2013)
Proteome-wide Identification of Poly(ADP-Ribosyl)ation Targets in Different Genotoxic Stress Responses
Stephanie Jungmichel et al.
MOLECULAR CELL (2013)
Role of poly(ADP-ribose) polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair
Mihaela Robu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Effects of PARP-1 Deficiency on Th1 and Th2 Cell Differentiation
M. Sambucci et al.
SCIENTIFIC WORLD JOURNAL (2013)
Hypomethylation of ETS Transcription Factor Binding Sites and Upregulation of PARP1 Expression in Endometrial Cancer
Fang-Fang Bi et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
F. Rojo et al.
ANNALS OF ONCOLOGY (2012)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes
Peter Bai et al.
FEBS LETTERS (2012)
Overexpression of chromatin assembly factor-1 p60, poly(ADP-ribose) polymerase 1 and nestin predicts metastasizing behaviour of oral cancer
Massimo Mascolo et al.
HISTOPATHOLOGY (2012)
Poly(ADP-Ribosyl)ation of High Mobility Group Box 1 (HMGB1) Protein Enhances Inhibition of Efferocytosis
Kasey Davis et al.
MOLECULAR MEDICINE (2012)
Poly(ADP-ribose) Polymerase-1 in Amyloid Beta Toxicity and Alzheimer's Disease
Joanna B. Strosznajder et al.
MOLECULAR NEUROBIOLOGY (2012)
Pleiotropic Cellular Functions of PARP1 in Longevity and Aging: Genome Maintenance Meets Inflammation
Aswin Mangerich et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Lack of association between Poly(ADP-ribose) polymerase (PARP) polymorphisms and rheumatoid arthritis in a Korean population
Kyeong-A Lee et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Marie-France Langelier et al.
SCIENCE (2012)
Cancer-related inflammation: Common themes and therapeutic opportunities
Frances R. Balkwill et al.
SEMINARS IN CANCER BIOLOGY (2012)
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
Lauren Averett Byers et al.
CANCER DISCOVERY (2012)
Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
Federica Laudisi et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
β-amyloid activates PARP causing astrocytic metabolic failure and neuronal death
Rosella Abeti et al.
BRAIN (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
PARP Inhibitor Treatment in Ovarian and Breast Cancer
[Anonymous]
CURRENT PROBLEMS IN CANCER (2011)
PARP-1 enhances the mismatch-dependence of 5'-directed excision in human mismatch repair in vitro
Yiyong Liu et al.
DNA REPAIR (2011)
PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity
Leonardo Cavone et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Reactive Oxygen Species (ROS)-Induced genetic and epigenetic alterations in human carcinogenesis
Dominique Ziech et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1-Dependent Cell Death (Parthanatos)
Yingfei Wang et al.
SCIENCE SIGNALING (2011)
PARP inhibitors: New tools to protect from inflammation
Vincenzo Giansanti et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Inhibition of ADP Ribosylation Prevents and Cures Helicobacter-Induced Gastric Preneoplasia
Isabella M. Toller et al.
CANCER RESEARCH (2010)
Increased poly(ADP-ribose) polymerase (PARP)-1 expression and activity are associated with inflammation but not goblet cell metaplasia in murine models of allergen-induced airway inflammation
Thomas Havranek et al.
EXPERIMENTAL LUNG RESEARCH (2010)
Role of High-Mobility Group Box 1 Protein and Poly(ADP-Ribose) Polymerase 1 Degradation in Chlamydia trachomatis-Induced Cytopathicity
Hangxing Yu et al.
INFECTION AND IMMUNITY (2010)
Evaluation of the Poly(ADP-ribose) Polymerase-1 Gene Variants in Alzheimer's Disease
Hsin-Ping Liu et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2010)
Increased Foxp3+ Regulatory T Cells in Poly(ADP-Ribose) Polymerase-1 Deficiency
Francesca Nasta et al.
JOURNAL OF IMMUNOLOGY (2010)
Poly(ADP-Ribose) Polymerase-1 Is a Determining Factor in Crm1-Mediated Nuclear Export and Retention of p65 NF-κB upon TLR4 Stimulation
Mourad Zerfaoui et al.
JOURNAL OF IMMUNOLOGY (2010)
Genetic Ablation of PARP-1 Protects Against Oxazolone-Induced Contact Hypersensitivity by Modulating Oxidative Stress
Attila Brunyanszki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Structural and Biophysical Studies of Human PARP-1 in Complex with Damaged DNA
Wayne Lilyestrom et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Raga Krishnakumar et al.
MOLECULAR CELL (2010)
A Cytoplasmic ATM-TRAF6-cIAP1 Module Links Nuclear DNA Damage Signaling to Ubiquitin-Mediated NF-κB Activation
Michael Hinz et al.
MOLECULAR CELL (2010)
The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies
Wael Y. Mansour et al.
NUCLEIC ACIDS RESEARCH (2010)
Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns
Paola Caiafa et al.
FASEB JOURNAL (2009)
Identification of the ADP-Ribosylation Sites in the PARP-1 Automodification Domain: Analysis and Implications
Zhihua Tao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
A Nuclear Poly(ADP-Ribose)-Dependent Signalosome Confers DNA Damage-Induced IκB Kinase Activation
Michael Stilmann et al.
MOLECULAR CELL (2009)
Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals
Giovanni Brambilla et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2009)
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE
Mauricio F. Farez et al.
NATURE IMMUNOLOGY (2009)
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease
Pal Pacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
PARP inhibitor tilts cell death from necrosis to apoptosis in cancer cells
Keqiang Ye
CANCER BIOLOGY & THERAPY (2008)
PARP-1 cooperates with Ptc1 to suppress medulloblastoma and basal cell carcinoma
Mirella Tanori et al.
CARCINOGENESIS (2008)
Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation
W. Lee Kraus
CURRENT OPINION IN CELL BIOLOGY (2008)
Poly(ADP-ribose) polymerase 1 accelerates single-strand break repair in concert with poly(ADP-ribose) glycohydrolase
Anna E. O. Fisher et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Activation of poly(ADP)-ribose polymerase (PARP-1) induces release of the pro-inflammatory mediator HMGB1 from the nucleus
Dara Ditsworth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
PARP inhibition reduces acute colonic inflammation in rats
Susana Sanchez-Fidalgo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes
Emese Toth-Zsamboki et al.
MOLECULAR MEDICINE (2006)
Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2
TM Kauppinen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Potential role of poly(adenosine 5′-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock
FG Soriano et al.
CRITICAL CARE MEDICINE (2006)
Parp-1 protects homologous recombination from interference by Ku and ligase IV in vertebrate cells
H Hochegger et al.
EMBO JOURNAL (2006)
Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-κB-dependent transcription
PO Hassa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Poly(ADP-Ribose) polymerase-1 activation in a primate model of multiple sclerosis
TM Kauppinen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Poly(ADP-ribosyl)ation in asthma and other lung diseases
L Virág
PHARMACOLOGICAL RESEARCH (2005)
Clinical perspectives of PARP inhibitors
G Graziani et al.
PHARMACOLOGICAL RESEARCH (2005)
The expression of PARP, NF-κB and parvalbumin is increased in Parkinson disease
J Soós et al.
NEUROREPORT (2004)
Failure to degrade poly(ADP-ribose) causes increased sensitivity to cytotoxicity and early embryonic lethality
DW Koh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments
ML Meyer-Ficca et al.
EXPERIMENTAL CELL RESEARCH (2004)
Crosstalk between PARP-1 and NF-κB modulates the promotion of skin neoplasia
D Martín-Oliva et al.
ONCOGENE (2004)
Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells
A Carrillo et al.
NUCLEIC ACIDS RESEARCH (2004)
Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation:: a link between demyelination and neuronal damage
A Diestel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Transcriptional coactivation of nuclear factor-κB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1
PO Hassa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane
T Nozaki et al.
CANCER SCIENCE (2003)
Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress
LN Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse
JMN de Murcia et al.
EMBO JOURNAL (2003)
A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis
M Pascual et al.
ARTHRITIS AND RHEUMATISM (2003)
Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts
TL Andreone et al.
JOURNAL OF IMMUNOLOGY (2003)
Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice
WM Tong et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats
A Chiarugi
BRITISH JOURNAL OF PHARMACOLOGY (2002)
GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat
E Mazzon et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor
SW Yu et al.
SCIENCE (2002)
The enzymatic and DNA binding activity of PARP-1 are not required for NF-κB coactivator function
PO Hassa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inhibition of poly( ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis
HB Jijon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
Share Paper
